{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:46:38Z","timestamp":1792115198134,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.7759\/cureus.117986","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:32:36Z","timestamp":1792114356000},"source":"Crossref","is-referenced-by-count":0,"title":["Anticholinergic Burden Scoring in Orthogeriatric Patients: A Two-Cycle Quality Improvement Audit"],"prefix":"10.7759","author":[{"given":"Yashwanth","family":"Sooranahalli Nabh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14706","article-title":"Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs","volume":"24 Suppl 1","author":"Yamada S","year":"2024","unstructured":"Yamada S, Mochizuki M, Atobe K, Kato Y. Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs. Geriatr Gerontol Int. 2024, 24 Suppl 1:81-7. 10.1111\/ggi.14706","journal-title":"Geriatr Gerontol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05584-z","article-title":"Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study among psychiatric outpatients in a tertiary care hospital","volume":"25","author":"Bidarolli M","year":"2025","unstructured":"Bidarolli M, Das B, Rawat VS, et al.. Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study among psychiatric outpatients in a tertiary care hospital. BMC Geriatr. 2025, 25:43. 10.1186\/s12877-024-05584-z","journal-title":"BMC Geriatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05394-3","article-title":"Anticholinergic burden and frailty in older inpatients: insights from analysis of admission and discharge medicines using four anticholinergic scales","volume":"24","author":"Mohammed MA","year":"2024","unstructured":"Mohammed MA, Chan AH, Wabe N, et al.. Anticholinergic burden and frailty in older inpatients: insights from analysis of admission and discharge medicines using four anticholinergic scales. BMC Geriatr. 2024, 24:1022. 10.1186\/s12877-024-05394-3","journal-title":"BMC Geriatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1505007","article-title":"Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment","volume":"12","author":"Pistorio S","year":"2025","unstructured":"Pistorio S, Scotto di Tella G, Canzanella V, et al.. Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment. Front Med (Lausanne). 2025, 12:1505007. 10.3389\/fmed.2025.1505007","journal-title":"Front Med (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad176","article-title":"Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis","volume":"52","author":"Braithwaite E","year":"2023","unstructured":"Braithwaite E, Todd OM, Atkin A, et al.. Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis. Age Ageing. 2023, 52:afad176. 10.1093\/ageing\/afad176","journal-title":"Age Ageing"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis","volume":"80","author":"Ruxton K","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015, 80:209-20. 10.1111\/bcp.12617","journal-title":"Br J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.310","article-title":"Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients","volume":"5","author":"Egberts A","year":"2017","unstructured":"Egberts A, van der Craats ST, van Wijk MD, Alkilabe S, van den Bemt PM, Mattace-Raso FU. Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients. Pharmacol Res Perspect. 2017, 5:e00310. 10.1002\/prp2.310","journal-title":"Pharmacol Res Perspect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2501","article-title":"Assessing risks of polypharmacy involving medications with anticholinergic properties","volume":"18","author":"Hanlon P","year":"2020","unstructured":"Hanlon P, Quinn TJ, Gallacher KI, et al.. Assessing risks of polypharmacy involving medications with anticholinergic properties. Ann Fam Med. 2020, 18:148-55. 10.1370\/afm.2501","journal-title":"Ann Fam Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-023-04095-7","article-title":"Anticholinergic exposure and its association with dementia\/Alzheimer's disease and mortality in older adults","volume":"23","author":"Poonawalla IB","year":"2023","unstructured":"Poonawalla IB, Xu Y, Gaddy R, et al.. Anticholinergic exposure and its association with dementia\/Alzheimer's disease and mortality in older adults. BMC Geriatr. 2023, 23:401. 10.1186\/s12877-023-04095-7","journal-title":"BMC Geriatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015196.pub2","article-title":"Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia","volume":"8","author":"Taylor-Rowan M","year":"2022","unstructured":"Taylor-Rowan M, Kraia O, Kolliopoulou C, et al.. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia. Cochrane Database Syst Rev. 2022, 8:CD015196. 10.1002\/14651858.CD015196.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen MS","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015, 15:31. 10.1186\/s12877-015-0029-9","journal-title":"BMC Geriatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00895-x","article-title":"Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: a systematic review of risk scales and models","volume":"38","author":"Al Rihani SB","year":"2021","unstructured":"Al Rihani SB, Deodhar M, Darakjian LI, et al.. Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: a systematic review of risk scales and models. Drugs Aging. 2021, 38:977-94. 10.1007\/s40266-021-00895-x","journal-title":"Drugs Aging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100102","article-title":"Managing anticholinergic burden in hospitalised older adults\u2014should our attention be better directed?","volume":"24","author":"Tai W","year":"2024","unstructured":"Tai W, Hampton J. Managing anticholinergic burden in hospitalised older adults\u2014should our attention be better directed?. Clin Med (Lond). 2024, 24:100102. 10.1016\/j.clinme.2024.100102","journal-title":"Clin Med (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2025.2546142","article-title":"Rethinking anticholinergic burden in older adults: innovative approaches to detection and management","volume":"18","author":"Phutietsile GO","year":"2025","unstructured":"Phutietsile GO, Nishtala PS. Rethinking anticholinergic burden in older adults: innovative approaches to detection and management. Expert Rev Clin Pharmacol. 2025, 18:551-62. 10.1080\/17512433.2025.2546142","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riad021.037","article-title":"491 Anticholinergic cognitive burden score in a cohort of nursing home patients: an observational study","volume":"31","author":"Clarke K","year":"2023","unstructured":"Clarke K, Weedle P, Fleming A. 491 Anticholinergic cognitive burden score in a cohort of nursing home patients: an observational study. Int J Pharm Pract. 2023, 31:32. 10.1093\/ijpp\/riad021.037","journal-title":"Int J Pharm Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.06.001","article-title":"Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review","volume":"21","author":"Nakham A","year":"2020","unstructured":"Nakham A, Myint PK, Bond CM, Newlands R, Loke YK, Cruickshank M. Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review. J Am Med Dir Assoc. 2020, 21:172-180.e5. 10.1016\/j.jamda.2019.06.001","journal-title":"J Am Med Dir Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.36346\/sarjms.2026.v08i02.004","article-title":"Protecting aging brains: a quality improvement project on reducing anticholinergic burden in patients aged \u226565 years","volume":"8","author":"El Tumi AS","year":"2026","unstructured":"El Tumi AS, Farooq UH. Protecting aging brains: a quality improvement project on reducing anticholinergic burden in patients aged \u226565 years. South Asian Res J Med Sci. 2026, 8:43-50. 10.36346\/sarjms.2026.v08i02.004","journal-title":"South Asian Res J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc G","year":"2016","unstructured":"Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016, 25:986-92. 10.1136\/bmjqs-2015-004411","journal-title":"BMJ Qual Saf"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S541108","article-title":"Anticholinergic burden and its association with hospitalisation risk and causes of admission in older adults with mild cognitive impairment or dementia","volume":"20","author":"Rahoo R","year":"2025","unstructured":"Rahoo R, Liau ZY, Low MJ, Kamaruzzaman SB, Francis B, Khor HM. Anticholinergic burden and its association with hospitalisation risk and causes of admission in older adults with mild cognitive impairment or dementia. Clin Interv Aging. 2025, 20:1661-70. 10.2147\/CIA.S541108","journal-title":"Clin Interv Aging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.871229","article-title":"Anticholinergic drug exposure increases the risk of delirium in older patients undergoing elective surgery","volume":"9","author":"Herrmann ML","year":"2022","unstructured":"Herrmann ML, Boden C, Maurer C, et al.. Anticholinergic drug exposure increases the risk of delirium in older patients undergoing elective surgery. Front Med (Lausanne). 2022, 9:871229. 10.3389\/fmed.2022.871229","journal-title":"Front Med (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf368.088","article-title":"3765 Reducing anticholinergic burden (ACB) within the elderly care wards through implementation of automated alerts","volume":"55","author":"Malik N","year":"2026","unstructured":"Malik N, Salman S, Ng K, Tan N. 3765 Reducing anticholinergic burden (ACB) within the elderly care wards through implementation of automated alerts. Age Ageing. 2026, 55:afaf368.088. 10.1093\/ageing\/afaf368.088","journal-title":"Age Ageing"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-025-01204-6","article-title":"Comparison of anticholinergic burden scales and their association with cognitive and functional impairment in older adults: a cross-sectional study using the REPOSI database","volume":"42","author":"Novella A","year":"2025","unstructured":"Novella A, Azab M, Pasina L. Comparison of anticholinergic burden scales and their association with cognitive and functional impairment in older adults: a cross-sectional study using the REPOSI database. Drugs Aging. 2025, 42:559-72. 10.1007\/s40266-025-01204-6","journal-title":"Drugs Aging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afag049","article-title":"Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study","volume":"55","author":"Wei K","year":"2026","unstructured":"Wei K, Sun S, Chen C, et al.. Thirty-two-year trends in anticholinergic burden and associated mortality among US older adults: a population-based study. Age Ageing. 2026, 55:10.1093\/ageing\/afag049","journal-title":"Age Ageing"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae277.067","article-title":"2441 Reducing anticholinergic burden in older adults from an acute geriatric ward\u2014a quality improvement activity using education","volume":"54","author":"Loh KY","year":"2025","unstructured":"Loh KY, Ho A, Lim K, Varman S. 2441 Reducing anticholinergic burden in older adults from an acute geriatric ward\u2014a quality improvement activity using education. Age Ageing. 2025, 54:afae277.067. 10.1093\/ageing\/afae277.067","journal-title":"Age Ageing"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afae277.015","article-title":"2825 Embedding the anticholinergic burden score and deprescribing into a collaborative community and secondary care frailty clinic","volume":"54","author":"Wright C","year":"2025","unstructured":"Wright C, McNamarra F, Kidd L, Heseltine D. 2825 Embedding the anticholinergic burden score and deprescribing into a collaborative community and secondary care frailty clinic. Age Ageing. 2025, 54:afae277.015. 10.1093\/ageing\/afae277.015","journal-title":"Age Ageing"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522778-anticholinergic-burden-scoring-in-orthogeriatric-patients-a-two-cycle-quality-improvement-audit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:32:37Z","timestamp":1792114357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522778-anticholinergic-burden-scoring-in-orthogeriatric-patients-a-two-cycle-quality-improvement-audit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.117986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}